Pharma Focus Europe

Experic Expands its Clinical Trial Storage and Logistics Services to Europe

Wednesday, February 28, 2024

Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services provider serving the biopharmaceutical industry, has announced the opening of a new facility in Dublin, Ireland. This facility aims to support global clinical trials, expand the company's global footprint, enhance the efficiency of its clinical trial supply services worldwide, and pave the way for future growth.

Brian Fagan, the Vice President of Operations at Experic, who brings over 25 years of experience in clinical trial supply, is spearheading this expansion effort. Fagan emphasized Experic's dedication to customer satisfaction, stating that they prioritize listening to customer feedback. In response to customers expressing a preference for more clinical trial supply services under the Experic umbrella, the company made it a strategic priority to expand its direct management of these services in Europe.

The new Experic facility in Dublin will provide monitored storage and logistics services across a 10,000 sq. ft. secure warehouse space. These services include cold storage and re-labeling capabilities, facilitating the rapid and reliable distribution of Investigational Medicinal Products (IMPs) and comparators for pharmaceutical companies conducting global clinical trials across Europe. The facility is scheduled to open in the second half of 2024 and will be staffed by local talent familiar with EU regulatory requirements, supported by Experic's expert project management team in the United States and the company's existing Global Partner Depot Network.

This expansion represents Experic's first physical venture into the EU market and is expected to enhance the efficiency and success of its trial services, benefiting its clients in the biopharmaceutical industry.



Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024